Health
Pfizer-BioNTech vaccine appears effective against mutation in new coronavirus variants: Study – The Straits Times
A study indicated the vaccine was effective in neutralising virus with the so-called N501Y mutation of the spike protein.. Read more at straitstimes.com.
NEW YORK (REUTERS) – Pfizer and BioNTech’s Covid-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in Britain and South Africa, according to a laboratory study conducted by the US drugmaker.
The not-yet peer reviewed study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in neutralising virus with the so-called N501Y mutation of the spike protein.
The mutation could be…
-
General24 hours agoYounger generations are moving away from traditional media to fill their entertainment hours
-
Business23 hours agoThese ASX 200 shares could rise 50% to 60%
-
General23 hours agoAustralia’s Myanmar community mourns earthquake losses
-
Noosa News24 hours agoQueensland’s film boom: How the Sunshine State is cementing its place as Hollywood’s favourite